Tocilizumab Shortage in Canada
2 of 15 products currently in shortage or anticipated
Is there a shortage of Tocilizumab in Canada?
Yes — 2 of 15 tracked Tocilizumab products currently have an active or anticipated shortage in Canada, as of 2026-10-29.
Avtozma, Actemra & Tyenne (Tocilizumab) Shortage in Canada
Whether tocilizumab — Actemra and its biosimilars Avtozma and Tyenne — is in shortage in Canada right now, what anticipated and avoided shortage reports mean, and what to ask before switching brands.
All Products
TYENNE
200MG · DIN 02552469
Resolved
TYENNE
400MG · DIN 02552477
Resolved
TYENNE
80MG · DIN 02552450
Resolved
TYENNE
162MG · DIN 02552485
Active Shortage
TYENNE
162MG · DIN 02552493
Active Shortage
AVTOZMA
400MG · DIN 02562049
Resolved
AVTOZMA
200MG · DIN 02562030
Resolved
ACTEMRA
400MG · DIN 02350114
Shortage Avoided
ACTEMRA
200MG · DIN 02350106
Shortage Avoided
ACTEMRA
80MG · DIN 02350092
Shortage Avoided
ACTEMRA
162MG · DIN 02483327
Shortage Avoided
ACTEMRA
162MG · DIN 02424770
No current shortage
AVTOZMA
162MG · DIN 02562065
No current shortage
AVTOZMA
80MG · DIN 02562022
No current shortage
AVTOZMA
162MG · DIN 02562057
No current shortage